Nikkei ends up as weak yen offers trade fear respite; SoftBank jumps

INSUBCONTINENT EXCLUSIVE:
TOKYO: Japan's Nikkei rebounded on Thursday as a weaker yen offered a temporary respite to trade war fears and lifted sentiment, while
index-heavyweight SoftBank soared after a source said a US hedge fund took a $1 billion stake in it. The Nikkei share average ended 1.2 per
cent higher at 22,187.96, outperforming the broader Topix, which was up 0.5 per cent at 1,709.68. The Nikkei's outperformance led the Nikkei
versus Topix, the so-called NT ratio, to 12.99, the highest since March 1999. SoftBank Group, the most traded stock by turnover, jumped 6.4
per cent , rising for 10 consecutive sessions after a source told Reuters that US hedge fund Tiger Global has built a stake worth more than
$1 billion in the company. The stock contributed a hefty positive 63 points to the Nikkei. The dollar firmed 0.3 per cent to 112.29 yen,
after breaking through the 112-barrier for the first time since Jan
10 after US economic data reaffirmed expectations that the Federal Reserve will hike interest rates two more times this year. Although a
weaker yen raised investors' risk appetite, notable gainers were defensive stocks such as pharmaceuticals and food companies. "Companies
which have relatively little impact from the global economic growth tend to attract buyers now as investors are still very cautious against
fears of trade tensions between the US and China," said Takuya Takahashi, a strategist at Daiwa Securities. Japanese stocks tumbled on
Wednesday along with a slide in global equities after US President Donald Trump's threat of imposing tariffs on another $200 billion of
Chinese goods deepened the trade row between the world's two largest economies. Soy sauce maker Kikkoman Corp surged 3.5 per cent and
brewery Asahi Group Holdings added 2.3 per cent. Drugmaker Eisai Co jumped 8.0 per cent to hover near its record high hit earlier this week
as investors continued to take heart from last week's announcement from the company and Biogen Inc that the final analysis of a mid-stage
trial of their Alzheimer's drug showed positive results for patients who received the highest dose. Meanwhile, convenience store operator
Lawson Inc fell as much as 3.3 per cent to hit a 5-1/2-year low of 6,350 yen before ending 1.4 per cent lower after the company's operating
profit fell 22 per cent on the year to 12.68 billion yen for the first quarter ended May, hit by rising system costs.